AMVISION-1: Brodalumab in participants with psoriatic arthritis

• Research type

  Research Study

• Full title

  A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1

• IRAS ID

  143187

• Contact name

  Iain McInnes

• Contact email

  Iain.McInnes@glasgow.ac.uk

• Sponsor organisation

  Amgen Ltd

• Eudract number

  2013-003554-25

• Clinicaltrials.gov Identifier

  NCT02029495

• REC name

  West of Scotland REC 1

• REC reference

  14/WS/0002

• Date of REC Opinion

  12 Mar 2014

• REC opinion

  Further Information Favourable Opinion